î
îŒ
ãã°ã€ã³
î
PolyPid Ltd
PYPDî¹
詳现ãã£ãŒãã衚瀺
4.210USD
-0.070-1.64%
çµå€Â 03/30, 16:00ïŒETïŒ15åé
ãã®æ ªäŸ¡
2.39Mæ䟡ç·é¡
æ倱é¡çŽè¿12ã¶æPER
î
Intraday
1m
30m
1h
D
W
M
D
æ¬æ¥
-1.64%
5æ¥é
+1.45%
1ã¶æ
-3.00%
6ã¶æ
+26.24%
幎åæ¥
-3.00%
1幎é
+53.65%
詳现ãã£ãŒãã衚瀺
TradingKey æ ªåŒã¹ã³ã¢
ããŒã¿ãäžååãªãããæ ªåŒã¹ã³ã¢ã¯å©çšã§ããŸããã
PolyPid Ltd ãã¥ãŒã¹
ææ°æ
å ±ããåŸ
ã¡ãã ãã...
財åææšî
EPS
äŒç€Ÿããé¢é£ããŒã¿ããŸã é瀺ãããŠããŸããã
ç·å£²äžé«
äŒç€Ÿããé¢é£ããŒã¿ããŸã é瀺ãããŠããŸããã
PolyPid Ltdã®äŒæ¥æ å ±î
Polypid Ltd is a biopharmaceutical company at the clinical stage, based in Israel . The company focuses on the development, production and commercialization of new, locally administered therapies to improve surgical results. The main product is PLEX technology, which is located in the place of surgery and ensures controlled and continuous delivery of medicines.
äŒæ¥ã³ãŒãPYPD
äŒæ¥åPolyPid Ltd
æé«çµå¶è²¬ä»»è
ãCEOãAkselbrad (Dikla Czaczkes)
ãŠã§ããµã€ãhttps://www.polypid.com
é¢é£éèåå
+0.96%
+1.56%
+0.85%
+2.90%
-1.28%
+1.78%
+1.47%
+0.07%
+0.00%
+2.70%
-2.08%
-0.13%
+0.72%
+2.03%
+2.33%
0.00%
+1.57%
-0.13%
+2.63%
+2.01%人æ°éæ
246.630
-2.170Â (-0.87%)
165.170
-2.350Â (-1.40%)
67956.690
+1335.290Â (+2.00%)
251.670
-23.670Â (-8.60%)
2073.150
+52.450Â (+2.60%)
355.280
-6.550Â (-1.81%)
4573.060
+62.280Â (+1.38%)
101.051
-3.211Â (-3.08%)
1.148
+0.001Â (+0.11%)
159.636
-0.023Â (-0.01%)
